FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

REGISTER

now for free

GD MacLean

Research Profile

Concepts & Ideas

Disorders

Procedures

Chemicals & Drugs

Activities & Behaviors

Image Processing, Computer-Assisted

Register to see full profile

Co-author Network

Register to see all co-authors

Publications

TOP 3
Robert G Pearcey; Michael D Brundage; P Drouin; J Jeffrey; D Johnston; Himu Lukka; GD MacLean; Luis Souhami; G Stuart; Dongsheng Tu
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.
M Palmer; J Parker; Shanu Modi; Charles Butts; Michael Smylie; A Meikle; M Kehoe; GD MacLean; M Longenecker
Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer.
Steve McQuarrie; Terence A Riauka; Richard P Baum; TR Sykes; Antoine A Noujaim; GR Boniface; GD MacLean; Alexander J B McEwan
The effects of circulating antigen on the pharmacokinetics and radioimmunoscintigraphic properties of 99m Tc labelled monoclonal antibodies in cancer patients.

Register to see all publications

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Register to see more

Geonetwork of GD MacLean (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Register to see more

All Publications

2002: Robert G Pearcey; Michael D Brundage; P Drouin; J Jeffrey; D Johnston; Himu Lukka; GD MacLean; Luis Souhami; G Stuart; Dongsheng Tu
Phase III trial comparing radical radiotherapy with and without cisplatin chemotherapy in patients with advanced squamous cell cancer of the cervix.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(4):966-72.
2001: M Palmer; J Parker; Shanu Modi; Charles Butts; Michael Smylie; A Meikle; M Kehoe; GD MacLean; M Longenecker
Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer.
Clinical lung cancer 2001;3(1):49-57; discussion 58.
1998: Steve McQuarrie; Terence A Riauka; Richard P Baum; TR Sykes; Antoine A Noujaim; GR Boniface; GD MacLean; Alexander J B McEwan
The effects of circulating antigen on the pharmacokinetics and radioimmunoscintigraphic properties of 99m Tc labelled monoclonal antibodies in cancer patients.
Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Société canadienne des sciences pharmaceutiques 1998;1(3):115-25.
1997: Steve McQuarrie; GD MacLean; GR Boniface; K Golberg; Alexander J B McEwan
Radioimmunoscintigraphy in patients with breast adenocarcinoma using technetium-99m labelled monoclonal antibody 170H.82: report of a phase II study.
European journal of nuclear medicine 1997;24(4):381-9.

Register to see more

Copyright © 2011 Elsevier Inc. All rights reserved.